Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-11

AUTHORS

Keaton S. Smetana, Jessie Dunne, Kevin Parrott, George A. Davis, Amy C. Schmelzer Collier, Mary Covell, Susan Smyth

ABSTRACT

Left ventricular thrombus (LVT) formation usually necessitates short term anticoagulation for thrombus resolution and to prevent embolic events. Historically, vitamin K antagonist therapy has been the treatment of choice. However, with the advent of direct acting anticoagulants, their role in the management of LVT is not clear. Patients were included if they had received rivaroxaban or apixaban for more than 1 day for LVT documented on imaging. The primary objective was resolution of LVT at 3 months based on assessment by an independent cardiologist review of initial and subsequent imaging results. The principle safety objective was to assess major or clinically relevant non-major bleeding using GUSTO, TIMI, and BARC bleeding criteria. During the 2-year study period seven patients were treated with rivaroxaban and three with apixaban. Two patients who had received apixaban and one on rivaroxaban were lost to follow up. In those with an initial and follow-up ECHO (n = 6) the median time to follow up imaging was 214 (IQR 33-414) days and complete LVT resolution was observed in 83% of patients. One patient on rivaroxaban had a bleeding events that was minimal (TIMI), Type 2 (BARC), or classified as mild (GUSTO) due to pulmonary hemorrhage. In those deemed not to be a candidate for vitamin K antagonist the use of rivaroxaban or apixaban may be a considered in the treatment of LVT. Further research in this area is needed to assess the efficacy and safety of using FXAI for treatment of LVT. More... »

PAGES

519-524

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-017-1560-7

DOI

http://dx.doi.org/10.1007/s11239-017-1560-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091917964

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28948507


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diagnostic Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Factor Xa Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Ventricles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rivaroxaban", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Pharmaceutical Services, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Doan Hall Room 368, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smetana", 
        "givenName": "Keaton S.", 
        "id": "sg:person.016635170627.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016635170627.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kentucky HealthCare", 
          "id": "https://www.grid.ac/institutes/grid.413001.7", 
          "name": [
            "Department of Pharmaceutical Services, University of Kentucky HealthCare, 800 Rose Street, H110, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dunne", 
        "givenName": "Jessie", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, 900 S Limestone Street, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parrott", 
        "givenName": "Kevin", 
        "id": "sg:person.011677516123.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011677516123.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kentucky HealthCare", 
          "id": "https://www.grid.ac/institutes/grid.413001.7", 
          "name": [
            "Department of Pharmaceutical Services, University of Kentucky HealthCare, 800 Rose Street, H110, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "George A.", 
        "id": "sg:person.011405133577.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405133577.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kentucky HealthCare", 
          "id": "https://www.grid.ac/institutes/grid.413001.7", 
          "name": [
            "Department of Internal Medicine, University of Kentucky HealthCare, 900 S Limestone Street, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Collier", 
        "givenName": "Amy C. Schmelzer", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kentucky HealthCare", 
          "id": "https://www.grid.ac/institutes/grid.413001.7", 
          "name": [
            "Department of Pharmaceutical Services, University of Kentucky HealthCare, 800 Rose Street, H110, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Covell", 
        "givenName": "Mary", 
        "id": "sg:person.0721735435.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721735435.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, 900 S Limestone Street, 40536, Lexington, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smyth", 
        "givenName": "Susan", 
        "id": "sg:person.01362775372.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362775372.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00380-014-0562-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000965614", 
          "https://doi.org/10.1007/s00380-014-0562-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1502000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004071762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2015.03.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005310473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2010.06.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006686160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/heartjnl-2012-301962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007767556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2012.11.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008029410"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1611594", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008159889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.joa.2016.01.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010040038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-9560-11-26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011020716", 
          "https://doi.org/10.1186/1477-9560-11-26"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-9560-11-26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011020716", 
          "https://doi.org/10.1186/1477-9560-11-26"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/814524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016906762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2016.05.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017007276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1107039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018510213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0905561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018974880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/fca.14.12", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020289427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2016.12.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023870082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.110.009449", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025074445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehs215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030848257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e318142be20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031017108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e318142be20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031017108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1510991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033147228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bcr-2014-203870", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041911460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.healun.2010.08.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044075522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1007903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044711794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.1412s3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044869520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1411800", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048273198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1009638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051578846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62343-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053051165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053311252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th10-04-0247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063292436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5543/tkda.2015.68054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072970536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079105798", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11", 
    "datePublishedReg": "2017-11-01", 
    "description": "Left ventricular thrombus (LVT) formation usually necessitates short term anticoagulation for thrombus resolution and to prevent embolic events. Historically, vitamin K antagonist therapy has been the treatment of choice. However, with the advent of direct acting anticoagulants, their role in the management of LVT is not clear. Patients were included if they had received rivaroxaban or apixaban for more than 1 day for LVT documented on imaging. The primary objective was resolution of LVT at 3 months based on assessment by an independent cardiologist review of initial and subsequent imaging results. The principle safety objective was to assess major or clinically relevant non-major bleeding using GUSTO, TIMI, and BARC bleeding criteria. During the 2-year study period seven patients were treated with rivaroxaban and three with apixaban. Two patients who had received apixaban and one on rivaroxaban were lost to follow up. In those with an initial and follow-up ECHO (n\u2009=\u20096) the median time to follow up imaging was 214 (IQR 33-414) days and complete LVT resolution was observed in 83% of patients. One patient on rivaroxaban had a bleeding events that was minimal (TIMI), Type 2 (BARC), or classified as mild (GUSTO) due to pulmonary hemorrhage. In those deemed not to be a candidate for vitamin K antagonist the use of rivaroxaban or apixaban may be a considered in the treatment of LVT. Further research in this area is needed to assess the efficacy and safety of using FXAI for treatment of LVT.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-017-1560-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "name": "Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series", 
    "pagination": "519-524", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "781e54f57f709d7e2eaeaa32f63bb8dc822c20fb500eb4e7b133314d8e589566"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28948507"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-017-1560-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091917964"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-017-1560-7", 
      "https://app.dimensions.ai/details/publication/pub.1091917964"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000601.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-017-1560-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-017-1560-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-017-1560-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-017-1560-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-017-1560-7'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      21 PREDICATES      75 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-017-1560-7 schema:about N00c2af1c24d64bdebabb662330352eb4
2 N2207942cf0ce4e9abdf602f71d607181
3 N222fd1f3393640be9c0bebd5cc3b079d
4 N2e83be1c49e84687954124da5be4cc94
5 N39205a5d45b14479b6fed22484900048
6 N42c8599e77ae4c17b59cc4e8129e84ed
7 N736bce47b3d1466c9fc0966dec3fa7f9
8 N75a453d540764bf38418298d937df6e1
9 N77bc60ac16374c0aad2e73afb7cb2cf3
10 N79b502496385449894bc4a622c0e91e2
11 N8db5263653f448cbb2de7d33358e26b8
12 N91aaaef218d34cb5a6781e5c093187fd
13 Nad2a6332051b4dd4bba9816431a1d76e
14 Nb244767c22864c4b94df923775fb672d
15 Nd3ce632d18134bdfb20ad146366b0f5b
16 Nf6c3242291e8486ab81ada28d7882c26
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Ne3f9ff528e564e37a6bb520a0a2cce54
20 schema:citation sg:pub.10.1007/s00380-014-0562-z
21 sg:pub.10.1186/1477-9560-11-26
22 https://app.dimensions.ai/details/publication/pub.1079105798
23 https://doi.org/10.1016/j.ahj.2015.03.017
24 https://doi.org/10.1016/j.ahj.2016.05.007
25 https://doi.org/10.1016/j.amjcard.2010.06.043
26 https://doi.org/10.1016/j.amjcard.2016.12.008
27 https://doi.org/10.1016/j.healun.2010.08.027
28 https://doi.org/10.1016/j.jacc.2012.11.019
29 https://doi.org/10.1016/j.joa.2016.01.009
30 https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.031
31 https://doi.org/10.1016/s0140-6736(13)62343-0
32 https://doi.org/10.1056/nejmc1411800
33 https://doi.org/10.1056/nejmoa0905561
34 https://doi.org/10.1056/nejmoa1007903
35 https://doi.org/10.1056/nejmoa1009638
36 https://doi.org/10.1056/nejmoa1107039
37 https://doi.org/10.1056/nejmoa1502000
38 https://doi.org/10.1056/nejmoa1510991
39 https://doi.org/10.1056/nejmoa1611594
40 https://doi.org/10.1093/eurheartj/ehs215
41 https://doi.org/10.1097/maj.0b013e318142be20
42 https://doi.org/10.1136/bcr-2014-203870
43 https://doi.org/10.1136/heartjnl-2012-301962
44 https://doi.org/10.1155/2014/814524
45 https://doi.org/10.1160/th10-04-0247
46 https://doi.org/10.1161/circulationaha.110.009449
47 https://doi.org/10.1378/chest.1412s3
48 https://doi.org/10.2217/fca.14.12
49 https://doi.org/10.5543/tkda.2015.68054
50 schema:datePublished 2017-11
51 schema:datePublishedReg 2017-11-01
52 schema:description Left ventricular thrombus (LVT) formation usually necessitates short term anticoagulation for thrombus resolution and to prevent embolic events. Historically, vitamin K antagonist therapy has been the treatment of choice. However, with the advent of direct acting anticoagulants, their role in the management of LVT is not clear. Patients were included if they had received rivaroxaban or apixaban for more than 1 day for LVT documented on imaging. The primary objective was resolution of LVT at 3 months based on assessment by an independent cardiologist review of initial and subsequent imaging results. The principle safety objective was to assess major or clinically relevant non-major bleeding using GUSTO, TIMI, and BARC bleeding criteria. During the 2-year study period seven patients were treated with rivaroxaban and three with apixaban. Two patients who had received apixaban and one on rivaroxaban were lost to follow up. In those with an initial and follow-up ECHO (n = 6) the median time to follow up imaging was 214 (IQR 33-414) days and complete LVT resolution was observed in 83% of patients. One patient on rivaroxaban had a bleeding events that was minimal (TIMI), Type 2 (BARC), or classified as mild (GUSTO) due to pulmonary hemorrhage. In those deemed not to be a candidate for vitamin K antagonist the use of rivaroxaban or apixaban may be a considered in the treatment of LVT. Further research in this area is needed to assess the efficacy and safety of using FXAI for treatment of LVT.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N390712772fa24200ac5bd9a8dababb2d
57 Nb768456042614d718d47c4b2043f4e48
58 sg:journal.1113719
59 schema:name Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series
60 schema:pagination 519-524
61 schema:productId N08808a748727407b9a2018f17405068c
62 N21a763c36beb443da2d1cda3fe085b83
63 N3d6aca0006954c6cb70eb332189e889c
64 Nbda6df5751974a0aae2b470f1ed55d54
65 Ne101c06a511b490ab198ebc7325ba113
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091917964
67 https://doi.org/10.1007/s11239-017-1560-7
68 schema:sdDatePublished 2019-04-10T19:21
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher Nf84485c0a5cd4959bbdef5de0e0d2336
71 schema:url http://link.springer.com/10.1007%2Fs11239-017-1560-7
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N00c2af1c24d64bdebabb662330352eb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Pyridones
77 rdf:type schema:DefinedTerm
78 N018b58d788b540fc879b819d1731b3ee schema:affiliation https://www.grid.ac/institutes/grid.413001.7
79 schema:familyName Collier
80 schema:givenName Amy C. Schmelzer
81 rdf:type schema:Person
82 N08808a748727407b9a2018f17405068c schema:name readcube_id
83 schema:value 781e54f57f709d7e2eaeaa32f63bb8dc822c20fb500eb4e7b133314d8e589566
84 rdf:type schema:PropertyValue
85 N0da190e636fe48c9b1758e8ffba84e90 rdf:first sg:person.011405133577.42
86 rdf:rest Nea960c2da07d49ee86049be7bae223c7
87 N1a59322cb2d440ef9cb547285525b977 rdf:first sg:person.011677516123.82
88 rdf:rest N0da190e636fe48c9b1758e8ffba84e90
89 N21a763c36beb443da2d1cda3fe085b83 schema:name pubmed_id
90 schema:value 28948507
91 rdf:type schema:PropertyValue
92 N2207942cf0ce4e9abdf602f71d607181 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Adult
94 rdf:type schema:DefinedTerm
95 N222fd1f3393640be9c0bebd5cc3b079d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Diagnostic Imaging
97 rdf:type schema:DefinedTerm
98 N2e83be1c49e84687954124da5be4cc94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Pyrazoles
100 rdf:type schema:DefinedTerm
101 N30f9298eadcc4045b5faebeb58379481 schema:affiliation https://www.grid.ac/institutes/grid.413001.7
102 schema:familyName Dunne
103 schema:givenName Jessie
104 rdf:type schema:Person
105 N390712772fa24200ac5bd9a8dababb2d schema:issueNumber 4
106 rdf:type schema:PublicationIssue
107 N39205a5d45b14479b6fed22484900048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Follow-Up Studies
109 rdf:type schema:DefinedTerm
110 N3d6aca0006954c6cb70eb332189e889c schema:name doi
111 schema:value 10.1007/s11239-017-1560-7
112 rdf:type schema:PropertyValue
113 N42c8599e77ae4c17b59cc4e8129e84ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 N736bce47b3d1466c9fc0966dec3fa7f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Rivaroxaban
118 rdf:type schema:DefinedTerm
119 N75a453d540764bf38418298d937df6e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Thrombosis
121 rdf:type schema:DefinedTerm
122 N77bc60ac16374c0aad2e73afb7cb2cf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Aged
124 rdf:type schema:DefinedTerm
125 N79b502496385449894bc4a622c0e91e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N8a13b5c873cd4ba2a95471bd59591290 schema:name Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, 900 S Limestone Street, 40536, Lexington, KY, USA
129 rdf:type schema:Organization
130 N8db5263653f448cbb2de7d33358e26b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Hemorrhage
132 rdf:type schema:DefinedTerm
133 N91aaaef218d34cb5a6781e5c093187fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Factor Xa Inhibitors
135 rdf:type schema:DefinedTerm
136 Nab6a5f387bcb4aa596544d1e99101f33 rdf:first sg:person.0721735435.47
137 rdf:rest Nc0c8cfad7ec045d7b5c06ee87463473e
138 Nad2a6332051b4dd4bba9816431a1d76e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 Nb244767c22864c4b94df923775fb672d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Treatment Outcome
143 rdf:type schema:DefinedTerm
144 Nb768456042614d718d47c4b2043f4e48 schema:volumeNumber 44
145 rdf:type schema:PublicationVolume
146 Nbda6df5751974a0aae2b470f1ed55d54 schema:name nlm_unique_id
147 schema:value 9502018
148 rdf:type schema:PropertyValue
149 Nc0c8cfad7ec045d7b5c06ee87463473e rdf:first sg:person.01362775372.06
150 rdf:rest rdf:nil
151 Nd0655ee3774e4d2fb0742722e0d39dd0 rdf:first N30f9298eadcc4045b5faebeb58379481
152 rdf:rest N1a59322cb2d440ef9cb547285525b977
153 Nd3ce632d18134bdfb20ad146366b0f5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Male
155 rdf:type schema:DefinedTerm
156 Nde7f74eed3d74758918906281183cc21 schema:name Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, 900 S Limestone Street, 40536, Lexington, KY, USA
157 rdf:type schema:Organization
158 Ne101c06a511b490ab198ebc7325ba113 schema:name dimensions_id
159 schema:value pub.1091917964
160 rdf:type schema:PropertyValue
161 Ne3f9ff528e564e37a6bb520a0a2cce54 rdf:first sg:person.016635170627.93
162 rdf:rest Nd0655ee3774e4d2fb0742722e0d39dd0
163 Nea960c2da07d49ee86049be7bae223c7 rdf:first N018b58d788b540fc879b819d1731b3ee
164 rdf:rest Nab6a5f387bcb4aa596544d1e99101f33
165 Nf6c3242291e8486ab81ada28d7882c26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Heart Ventricles
167 rdf:type schema:DefinedTerm
168 Nf84485c0a5cd4959bbdef5de0e0d2336 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
174 schema:name Clinical Sciences
175 rdf:type schema:DefinedTerm
176 sg:journal.1113719 schema:issn 0929-5305
177 1573-742X
178 schema:name Journal of Thrombosis and Thrombolysis
179 rdf:type schema:Periodical
180 sg:person.011405133577.42 schema:affiliation https://www.grid.ac/institutes/grid.413001.7
181 schema:familyName Davis
182 schema:givenName George A.
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405133577.42
184 rdf:type schema:Person
185 sg:person.011677516123.82 schema:affiliation Nde7f74eed3d74758918906281183cc21
186 schema:familyName Parrott
187 schema:givenName Kevin
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011677516123.82
189 rdf:type schema:Person
190 sg:person.01362775372.06 schema:affiliation N8a13b5c873cd4ba2a95471bd59591290
191 schema:familyName Smyth
192 schema:givenName Susan
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362775372.06
194 rdf:type schema:Person
195 sg:person.016635170627.93 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
196 schema:familyName Smetana
197 schema:givenName Keaton S.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016635170627.93
199 rdf:type schema:Person
200 sg:person.0721735435.47 schema:affiliation https://www.grid.ac/institutes/grid.413001.7
201 schema:familyName Covell
202 schema:givenName Mary
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721735435.47
204 rdf:type schema:Person
205 sg:pub.10.1007/s00380-014-0562-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000965614
206 https://doi.org/10.1007/s00380-014-0562-z
207 rdf:type schema:CreativeWork
208 sg:pub.10.1186/1477-9560-11-26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011020716
209 https://doi.org/10.1186/1477-9560-11-26
210 rdf:type schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1079105798 schema:CreativeWork
212 https://doi.org/10.1016/j.ahj.2015.03.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005310473
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/j.ahj.2016.05.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017007276
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/j.amjcard.2010.06.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006686160
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/j.amjcard.2016.12.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023870082
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/j.healun.2010.08.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044075522
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/j.jacc.2012.11.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008029410
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/j.joa.2016.01.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010040038
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053311252
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/s0140-6736(13)62343-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053051165
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1056/nejmc1411800 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048273198
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1056/nejmoa0905561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018974880
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1056/nejmoa1007903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044711794
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1056/nejmoa1009638 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051578846
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmoa1107039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018510213
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejmoa1502000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004071762
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1056/nejmoa1510991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033147228
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1056/nejmoa1611594 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008159889
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1093/eurheartj/ehs215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030848257
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1097/maj.0b013e318142be20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031017108
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1136/bcr-2014-203870 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041911460
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1136/heartjnl-2012-301962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007767556
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1155/2014/814524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016906762
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1160/th10-04-0247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063292436
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1161/circulationaha.110.009449 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025074445
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1378/chest.1412s3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044869520
261 rdf:type schema:CreativeWork
262 https://doi.org/10.2217/fca.14.12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020289427
263 rdf:type schema:CreativeWork
264 https://doi.org/10.5543/tkda.2015.68054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072970536
265 rdf:type schema:CreativeWork
266 https://www.grid.ac/institutes/grid.412332.5 schema:alternateName The Ohio State University Wexner Medical Center
267 schema:name Department of Pharmaceutical Services, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Doan Hall Room 368, 43210, Columbus, OH, USA
268 rdf:type schema:Organization
269 https://www.grid.ac/institutes/grid.413001.7 schema:alternateName University of Kentucky HealthCare
270 schema:name Department of Internal Medicine, University of Kentucky HealthCare, 900 S Limestone Street, 40536, Lexington, KY, USA
271 Department of Pharmaceutical Services, University of Kentucky HealthCare, 800 Rose Street, H110, 40536, Lexington, KY, USA
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...